INSIGHTS ON PHARMACEUTICAL PACKAGING

PHARMACEUTICAL PACKAGING SOLUTIONS

  • Maintain cell integrity and reliable results with ready-to-use, preservative-free solutions designed to prevent contamination and support consistent fluid quality in sensitive workflows.

  • Mikart manufactures a range of blister pack solutions — including blister pack tablets, 2-piece hard- and softgel capsules, and more — as part of our commercial pharmaceutical packaging and clinical trial packaging services.

  • Ensure reliable, reproducible results in demanding laboratory workflows with ultra-pure water. Tight impurity control and consistent standards minimize contamination risks in sensitive applications.

  • The VeriPac 465 performs leak detection based on the basic principles of physics and does not require the use of trace gasses or sample preparation to perform the test. The VeriPac 465 core technology is based on the ASTM vacuum decay leak test method (F2338) recognized by the FDA as a consensus standard for package integrity testing. This test method was developed using VeriPac leak test instruments.

  • A generic drug must contain the same active ingredients as the original formulation. According to the U.S. Food and Drug Administration (FDA), generic drugs are identical or within an acceptable bioequivalent range to the brand-name counterpart with respect to pharmacokinetic and pharmacodynamic properties.